cGxP.wire https://validator.w3.org/feed/docs/rss2.html AIM ImmunoTech Advances Ampligen Strategy in Pancreatic Cancer Genentech Reports Positive Phase III evERA Results for Giredestrant Roswell Park and Generate Launch GB-5267 CAR T Trial BioCardia Files Revised FDA De Novo Submission for Helix Amplio Pharma Reports Positive NovoBioJect Phase 1b Data Trethera Gains FDA Fast Track for TRE-515 in NSCLC Regeneron Advances Ubamatamab in LGSOC Arvinas to Present ARV-102 Biomarker Data in Parkinson’s Disease Inspire Medical Systems Announces New CPT Codes for Inspire V Cullinan Initiates FDA NDA Submission for Zipalertinib Agomab Reports Positive STENOVA OLE Data for Ontunisertib BiomEdit Receives USDA License for Poultry Biologic VertigoDx Gains FDA Clearance for SmartVertigo System Pierre Fabre Resubmits Tabelecleucel BLA to FDA Shattuck Labs Advances SL-325 in Hidradenitis Suppurativa Monte Rosa Reports Positive Phase 1 MRT-8102 Results Genentech Reports Real-World Vabysmo Data Across Retinal Diseases Pfizer Reports Phase 2 Tilrekimig Data in Atopic Dermatitis Regeneron Reports Phase 2 Trevogrumab COURAGE Data Neurocrine Advances Prader-Willi Syndrome Research Q32 Bio Reports Bempikibart Phase 2 Alopecia Areata Data Halozyme Appoints Jim Daly to Board of Directors EpiSign Launches METRIC 5-base for Genome Analysis Castle Biosciences Reports EADV Data on DecisionDx-Melanoma Suvoda Expands Global Clinical Trial Data Experience Merck’s Tulisokibart Meets Phase 2b Endpoints in HS Lundbeck Reports Phase IV THRIVE Results for VYEPTI Regeneron and Sanofi Expand Long-Acting Antibody Alliance Bristol Myers Squibb Wins FDA Approval for Pediatric CAMZYOS Astrocyte Pharmaceuticals Raises $9.5M for AST-004 Tectonic Therapeutic Advances TX2100 in HHT With FDA Fast Track LEO Pharma Reports New Tralokinumab Data in Atopic Dermatitis Roche Reports Positive Phase III Giredestrant Results in Advanced Breast Cancer LEO Pharma Presents New Delgocitinib Data in Chronic Hand Eczema Samsung Bioepis and Teva Expand Biosimilar Partnership Atsena Reports 18-Month ATSN-201 Results in XLRS Roche Reports Real-World Vabysmo Data Across Major Retinal Conditions Zealand Pharma Reports Phase III Survodutide Results in Obesity and Type 2 Diabetes Atrogi Reports Positive Human Data for ATR-258 Boehringer Ingelheim Reports Phase III Survodutide Data in Obesity and T2D Moleculin Reports Positive MIRACLE Interim Results in R/R AML Phathom Advances VOQUEZNA in Non-Erosive GERD Nasus Pharma Advances NS003 Intranasal Ondansetron Into Phase 1 Corbus Advances CRB-701 in 2L+ Oropharyngeal Cancer argenx Reports New VYVGART Data in Myasthenia Gravis and CIDP Acurx Enrolls First Patient in Ibezapolstat Trial Novo Nordisk Reports Real-World Wegovy Pill Data AbbVie Advances Zumilokibart in Atopic Dermatitis Airway Therapeutics Wins $1.9M NIH Grant for Zelpultide Syra Health Wins Three-Year Mississippi Public Health Award